Gaetana Sterrantino

9PUBLICATIONS
27CO-AUTHORS
Behavioural epidemiologyRespiratory diseasesPharmacogenomicsMajor global burdens of diseaseGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Oct 31, 2024
Comparing the long-term effectiveness and safety of dolutegravir/lamivudine versus bictegravir/emtricitabine/tenofovir alafenamide fumarate as first-line regimens: a real life multicentre cohort.

Arturo Ciccullo, Gianmaria Baldin, Adriana Cervo

|Jan 11, 2024
Prevalence and Phenotypic Susceptibility to Doravirine of the HIV-1 Reverse Transcriptase V106I Polymorphism in B and Non-B Subtypes.

Federica Giammarino, Adolfo de Salazar, Isabelle Malet

|May 27, 2023
Efficacy and Durability of Dolutegravir- or Darunavir-Based Regimens in ART-Naïve AIDS- or Late-Presenting HIV-Infected Patients.

Massimiliano Fabbiani, Melissa Masini, Barbara Rossetti

|Oct 22, 2022
Analysing the efficacy and tolerability of dolutegravir plus either rilpivirine or lamivudine in a multicentre cohort of virologically suppressed PLWHIV.

A Ciccullo, G Baldin, V Borghi

|Jan 22, 2022
Real-Life Impact of Drug Toxicity on Dolutegravir Tolerability: Clinical Practice Data from a Multicenter Italian Cohort.

Arturo Ciccullo, Gianmaria Baldin, Vanni Borghi

|Jul 28, 2021
Efficacy and durability of two- vs. three-drug integrase inhibitor-based regimens in virologically suppressed HIV-infected patients: Data from real-life ODOACRE cohort.

Massimiliano Fabbiani, Barbara Rossetti, Arturo Ciccullo

Pageof 2

Frequent Collaborators

6 joint publications

Gianmaria Baldin

5 joint publications

Arturo Ciccullo

3 joint publications

Andrea Giacomelli

3 joint publications

Giordano Madeddu